Legal Representation
Attorney
Elizabeth M. O'Donoghue
USPTO Deadlines
Next Deadline
165 days remaining
NOA E-Mailed - SOU Required
Due Date
June 23, 2026
Extension Available
Until December 23, 2026
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 28, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 28, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 22, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 29, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 26, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 13, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 13, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 13, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
Classification
International Classes
005